Use of NK1 knockout mice to analyze substance P-induced edema formation

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 277, Issue 2 46-2, 1999, Pages

  Cao, Thong ^a   Gerard, Norma P ^b   Brain, Susan D ^a,c  

^a School of Economics and Political Science   (United Kingdom)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Edema formation; Neurokinin 1 knockout mouse; Neurokinin 1 receptor; Neurokinins; Rat skin; Substance P; Tachykinins

Indexed keywords

5 AMINOVALERYLSUBSTANCE P [7-11][9 PROLINE 10 (N METHYLLEUCINE)]; CAPSAICIN; HISTAMINE H1 RECEPTOR ANTAGONIST; MAST CELL DEGRANULATING PEPTIDE; MEPYRAMINE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR AGONIST; SEPTIDE; SUBSTANCE P; TACHYKININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; KNOCKOUT MOUSE; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN EDEMA;

EID: 0032833684     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.277.2.r476     Document Type: Article

References (30)

1. Ahluwalia, A., C. De Felipe, J. O'Brien, S. P. Hunt, and M. Perretti. Impaired IL-1β-induced neutrophil accumulation in tachykinin NK-1 receptor knockout mice. Br. J. Pharmacol. 124: 1013-1015, 1998.
2. Ahluwalia, A., S. Giuliani, and C. A. Maggi. Demonstration of a "septide sensitive" inflammatory response in rat skin. Br. J. Pharmacol. 116: 2170-2174, 1995.
3. Bienenstock, J., G. MacQueen, P. Sestini, J. S. Marshall, R. H. Stead, and M. H. Perdue. Mast cell/nerve interactions in vitro and in vivo. Am. Rev. Respir. Dis. 143: S55-S58, 1991.
4. Biro, T., M. Maurer, S. Modarres, N. E. Lewin, C. Brodie, G. Acs, P. Acs, R. Paus., and P. M. Blumberg. Characterization of functional vanilloid receptors expressed by mast cells. Blood 91: 1332-1340, 1998.
5. Bozic, C., B. Lu, U. E. Hopken, C. Gerard, and N. P. Gerard. Neurogenic amplification of immune complex inflammation. Science 273: 1722-1725, 1996.
6. Brain, S. D., and T. J. Williams. Inflammatory edema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br. J. Pharmacol. 86: 855-860, 1985.
7. Brain, S. D., T. J. Williams, J. R. Tipping, H. R. Morris, and I. MacIntyre. Calcitonin gene-related peptide is a potent vasodilator. Nature 313: 54-56, 1985.
8. Cao, Y. Q., P. W. Mantyh, E. J. Carlson, A. Gillespie, C. J. Epstein, and A. I Basbaum. Primary afferent tachykinins are required to experience moderate to intense pain. Nature 392: 390-394, 1998.
9. Castagliuolo, I., M. Reigler, A. Pasha, S. Nikulasson, B. Lu, C. Gerard, and N. P. Gerard. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis. J. Clin. Invest. 101: 1547-1550, 1998.
10. Caterina, M. J., M. A. Schumacher, M. Tominaga, T. A. Rosen, J. A. Levine, and A. Julius. The capsaicin receptor: heat-activated ion channel in the pain pathway. Nature 389: 816-824, 1997.
11. Ciucci, A., C. Palma, S. Manzini, and T. M. Werge. Point mutation increases a form of the NK-1 receptor with high affinity for neurokinin A and B and septide. Br. J. Pharmacol. 125: 393-340, 1998.
12. Delay-Goyet, P., H. Satoh, and J. M. Lundberg. Relative involvement of substance P and CGRP mechanisms in antidromic vasodilatation in the rat skin. Acta Physiol. Scared. 146: 537-538, 1992.
13. Devillier, P., G. Drapeau, M. Renoux, and D. Regoli. Role of the N-terminal arginine in the histamine-releasing activity of substance P and related peptides. Eur. J. Pharmacol. 168: 53-60, 1989.
14. 1 receptor antagonist. Eur. J. Pharmacol. 250: 403-413, 1993.
15. 8-37) on skin vasodilatation and edema induced by stimulation of the rat saphenous nerve. Br. J. Pharmacol. 110: 772-776, 1993.
16. Felipe, C. D., J. F. Herrero, J. A. O'Brien, J. A. Palmer, C. A. Doyle, A. J. H. Smiths, J. M. A. Laird, C. Belmonte, F. Cervero, and S. P. Hunt. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392: 394-397, 1998.
17. Foreman, J. C., C. C. Jordan, P. Oehme, and H. Renner. Structure activity relationships for some substance P-related peptides that cause wheal and flare reactions in human-skin. J. Physiol. (Lond.) 335: 449-465, 1993.
18. Inoue, H., N. Nagata, and Y. Koshihara. Participation of serotonin in capsaicin-induced mouse ear edema. Jpn. J. Pharmacol. 69: 61-68, 1995.
19. Kiernan, J. A. A pharmacological and histological investigation of the involvement of mast cells in cutaneous axon reflex vasodilatation. Q. J. Exp. Physiol. 60: 123-130, 1975.
20. Kowalski, M. L., and M. A. Kaliner. Neurogenic inflammation, vascular permeability, and mast cells. J. Immunol. 140: 3905-3911, 1988.
21. Kowalski, M. L., M. S. Kowalski, and M. A Kaliner. Neurogenic inflammation, vascular permeability, and mast cells. II. Additional evidence indicating that mast cells are not involved in neurogenic inflammation. J. Immunol. 145: 1214-1221, 1990.
22. 2 tachykinin receptors and their involvement in histamine release in a murine mast cell line. Neuropeptides 21: 65-72, 1992.
23. Lembeck, F., J. Donnerer, M. Tsuchiya, and A. Nagahisa. The non-peptide tachykinin antagonist, CP-96,345, is a potent inhibitor of neurogenic inflammation. Br. J. Pharmacol. 105: 527-530, 1992.
24. Lembeck, F., and P. Holzer. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch. Pharmacol. 310: 175-183, 1979.
25. Lilly, C. M., A. E. Hall, I. W. Rodger, L. Kobzik, K. J. Haley, and J. M. Drazen. Substance P-induced histamine release in tracheally perfused pig lungs. J. Appl. Physiol. 78: 1234-1241, 1995.
26. Maggi, C. A. The mammalian tachykinin receptors. Gen. Pharmacol. 26: 911-944, 1995.
27. Maggi, C. A., and T. W. Schwartz. The dual nature of the tachykinin NK-1 receptor. Trends Pharmacol. Sci. 18: 351-355, 1997.
28. Petitet, F., M. Saffroy, Y. Torrens, S. Lavielle, G. Chassaing, D. Loeuillet, J. Glowenski, and J. Beaujouan. Possible existence of a new tachykinin receptor subtype in the guinea pig ileum. Peptides 13: 383-388, 1992.
29. Tausk, F., and B. Undem. Exogenous but not endogenous substance P release histamine from isolated human skin fragments. Neuropeptides 29: 351-355, 1995.
30. Zimmer, A., A. M. Zimmer, J. Baffi, T. Usdin, K. Reynolds, M. Konig, M. Palkovits, and E. Mezey. Hypoalgesia in mice with a targeted deletion of the tachykinin gene. Neurobiology (Bp.) 95: 2630-2635, 1998.